Drugs / Polyethylene Glycol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03448770 | Aug 2017 → Jul 2018 | cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyethylene Glycol | “The Polyethylene Glycol group will get 17 gm of PEG (Polyethylene Glycol) administered orally or via nasogastric tube.” NCT03448770 ↗ |
| Known as | PEG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03448770 ↗ |
| Route | Oral | “administered orally or via nasogastric tube” NCT03448770 ↗ |
| Route | Other | “administered orally or via nasogastric tube” NCT03448770 ↗ |